Cencora Inc
F:ABG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cencora Inc
F:ABG
|
US |
|
Apex Critical Metals Corp
F:KL9
|
CA |
|
G
|
Globant SA
F:2G2
|
LU |
|
B
|
Banco Bradesco SA
BMV:BBDN
|
BR |
Intrinsic Value
Is ABG undervalued or overvalued?
See the intrinsic value estimate for 
Cencora Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Cencora Does
Cencora is one of the largest drug distributors in the United States and a major service provider to the pharmaceutical supply chain. It buys medicines and medical products from drug makers, stores them, and delivers them to pharmacies, hospitals, doctors’ offices, clinics, and other healthcare providers. It also offers support services such as specialty drug handling, packaging, consulting, and logistics for manufacturers and healthcare customers.
- Headquarters
- United States of America US
- Employees
- 49 000
- IPO date
- May 28, 1996
Cencora has a narrow economic moat
Spreading warehouse and delivery costs across a large volume of medicines helps Cencora serve customers at costs smaller distributors struggle to match. Its ordering and inventory systems also give customers practical reasons to stay, although McKesson and Cardinal Health offer strong alternatives.
Read the full moat analysis
Revenue & Expenses Breakdown
Cencora Inc
Earnings Waterfall
Cencora Inc
The intrinsic value for Cencora Inc (ABG) under the Base Case is hidden EUR.
Compared with the current market price of 300.8 EUR, the stock appears hidden.